Advisory Research Inc Glaukos Corp Transaction History

Advisory Research Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$54.18 - $65.64 $1.15 Million - $1.39 Million	-21,209 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$58.58 - $83.91 $1.28 Million - $1.84 Million	-21,892 Reduced 50.79%	21,209 $1.33 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $798,308 - $988,125	12,554 Added 41.1%	43,101 $3.25 Million
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $115,557 - $183,389	-2,277 Reduced 6.94%	30,547 $2.39 Million
Q4 2018 Feb 13, 2019	SELL	$52.18 - $67.93 $459,810 - $598,599	-8,812 Reduced 21.16%	32,824 $1.84 Million
Q3 2018 Nov 13, 2018	BUY	$38.13 - $68.37 $1.59 Million - $2.85 Million	41,636 New	41,636 $2.7 Million
Q4 2017 Feb 08, 2018	SELL	$24.5 - $36.01 $441,686 - $649,188	-18,028 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $563,555 - $757,716	18,028	18,028 $595,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.73B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.